Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	85.41	33.22	26.75	26.83	70.1
Short-Term Investments	51.44	150.24	60.04	91.6	-
Cash & Short-Term Investments	136.85	183.45	86.79	118.43	70.1
Cash Growth	-25.40%	111.38%	-26.71%	68.95%	-24.33%
Other Current Assets	5.17	11.85	3.39	2.31	2.11
Total Current Assets	142.02	195.3	90.18	120.74	72.2
Net Property, Plant & Equipment	2.69	3.72	3.76	3.69	4.46
Other Long-Term Assets	1.13	1.2	2	1.98	2.01
Total Assets	145.84	200.23	95.94	126.41	78.67
Accounts Payable	5.22	2.42	1.28	1.69	1.66
Accrued Expenses	58.47	20.87	7.39	8.41	6.59
Current Portion of Leases	1.11	1.06	0.84	0.61	0.59
Total Current Liabilities	64.8	24.36	9.51	10.71	8.85
Long-Term Leases	2.96	4.06	4.71	4.8	5.41
Total Long-Term Liabilities	2.96	4.06	4.71	4.8	5.41
Total Liabilities	67.76	28.41	14.22	15.5	14.25
Common Stock	0.08	0.06	0.04	0.04	0.02
Additional Paid-in Capital	512.78	440.76	270.15	262.5	180.65
Accumulated Other Comprehensive Income	0.05	0.15	0.08	-0.03	-
Retained Earnings	-434.83	-269.16	-188.55	-151.61	-116.25
Shareholders' Equity	78.09	171.81	81.72	110.9	64.41
Total Liabilities & Equity	145.84	200.23	95.94	126.41	78.67
Total Debt	4.07	5.12	5.55	5.41	6
Net Cash (Debt)	132.79	178.34	81.24	113.02	64.1
Net Cash Growth	-25.54%	119.51%	-28.12%	76.33%	-25.58%
Net Cash Per Share	1.82	2.91	1.85	4.39	3.73
Book Value	78.09	171.81	81.72	110.9	64.41
Book Value Per Share	1.07	2.80	1.86	4.31	3.75
Tangible Book Value	78.09	171.81	81.72	110.9	64.41
Tangible Book Value Per Share	1.07	2.80	1.86	4.31	3.75

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q